---
schema_version: "secwatch.filing_event.v1"
accession: "0000072331-25-000053"
form_type: "8-K"
ticker: "NDSN"
cik: "0000072331"
company_name: "NORDSON CORP"
filed_at: "2025-05-28T23:59:59+00:00"
generated_at: "2026-05-20T09:10:56.733182+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Nordson Q2 FY2025 sales $683M (+5%), adj EPS $2.42 beats midpoint; Q3 guide $710-750M

## Summary
- Q2 sales $683M (+5% YoY) with 8% acquisition benefit offset by 2% organic decline.
- Reported EPS $1.97 vs $2.05 prior year; adjusted EPS $2.42 (+3% YoY) above guidance midpoint.
- Advanced Technology Solutions organic sales +18% YoY; Medical & Fluid Solutions +20% (incl. Atrion).
- Q3 guidance: sales $710-$750M, adjusted EPS $2.55-$2.75 per diluted share.
- Backlog grew ~5% sequentially; company repurchased $85M in shares during the quarter.

## SEC filing metadata
- accession: 0000072331-25-000053
- form_type: 8-K
- ticker: NDSN
- cik: 0000072331
- company_name: NORDSON CORP
- filed_at: 2025-05-28T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/72331/000007233125000053/0000072331-25-000053-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/72331/000007233125000053/ndsn-20250528.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000072331-25-000053
- JSON: https://secwatch.observer/filing/0000072331-25-000053.json
- Plain text: https://secwatch.observer/filing/0000072331-25-000053.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
